Results 61 to 70 of about 971 (151)

Clopidogrel resistance in patients with acute coronary syndrome

Терапевтический архив, 2010
Aim: to reveal the frequency of clopidogrel resistance in patients with acute coronary syndrome (ACS) and its impact on prognosis in these patients. Subjects and methods. Seventy-five clopidogrel-treated patients with ACS were followed up.
N S Frolova, R M Shakhnovich, O V Sirotkina, A B Dobrovolsky, M Ya Ruda   +4 more
doaj  

Comparison of Clopidogrel and Ticlopidine/Ginkgo Biloba in Patients With Clopidogrel Resistance and Carotid Stenting

Frontiers in Neurology, 2019
Background and Purpose: Patients undergoing carotid artery stenting (CAS) who show low responsiveness to clopidogrel may have a higher risk of peri-procedural embolic events.
Jong-Won Chung, Suk Jae Kim, Jaechun Hwang, Mi Ji Lee, Jun Lee, Kyung-Yul Lee, Man-Seok Park, Sang Min Sung, Keon Ha Kim, Pyoung Jeon, Oh Young Bang   +10 more
doaj   +1 more source

Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center

Indian Heart Journal, 2016
Aims and objectives: Although clopidogrel combined with aspirin is the most commonly used dual drug combination to avert thrombotic events in patients with coronary artery disease, the poor responsiveness to clopidogrel remains a concern.
Jamshed J. Dalal, Aarti Digrajkar, Alap Gandhi   +2 more
doaj   +1 more source

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD) [PDF]

, 2021
Mohammed Ahmed Akkaif, Nur Aizati Athirah Daud, Abubakar Sha’aban, Mah Lee Ng, Muhamad Ali SK Abdul Kader, Dzul Azri Mohamed Noor, Baharudin Ibrahim   +6 more
openalex   +1 more source

The Effect of CYP2C19 and Nongenetic Factors on Clopidogrel Responsiveness in the MENA Region: A Systematic Review

Clinical and Applied Thrombosis/Hemostasis, 2019
Clopidogrel is the cornerstone antiplatelet used in the treatment and prevention of thrombotic events. Some studies examined the effect of CYP2C19 polymorphism and nongenetic factors on clopidogrel response in the Middle East and North Africa (MENA ...
Zainab Ali Msc, Hazem Elewa PhD
doaj   +1 more source

Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’ [PDF]

, 2006
Alan D. Michelson, Matthew D. Linden, M.I. Furman, Yun Li, M.R. BARNARD, Marsha L. Fox, Wei C. Lau, Thomas J. McLaughlin, Andrew L. Frelinger   +8 more
openalex   +1 more source

Multiple Recurrent Stent Thrombosis in a Patient with Coexisting Clopidogrel Resistance and Increased Anticardiolipin Antibodies: A Case Report

Case Reports in Medicine, 2010
The antiphospholipid syndrome (APS) is a common cause of both arterial and venous thrombosis. While studies exist demonstrating the role of APS in coronary artery bypass graft failure, its role in stent thrombosis is less clearly documented.
Erik H. Middlebrooks, Mukta Panda
doaj   +1 more source

Aspirin and clopidogrel resistance in patients with diabetes mellitus [PDF]

, 2006
André Scheen, Dominique Legrand
openalex   +1 more source

Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China [PDF]

, 2022
Rong Chang, Wenqin Zhou, Yi Ye, Xiaofei Zhang, Yanmin Liu, Jinchun Wu   +5 more
openalex   +1 more source

Effect of proton pump inhibitors on platelet inhibition activity of clopidogrel in Chinese patients with percutaneous coronary intervention

Vascular Health and Risk Management, 2011
Joanne Kwan1, Wah Wah Htun2, Yili Huang3, Wilson Ko3, Tak W Kwan31Boston University, Boston, MA, USA; 2Lutheran Medical Center, Brooklyn, NY, USA; 3Beth Israel Medical Center, New York, NY, USABackground: The purpose of this study was to examine the ...
Kwan T, Kwan, Huang, Htun, Ko
doaj